This HTML5 document contains 115 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34410616
rdf:type
wikibase:Item
schema:description
2004年論文 2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած vědecký článek artigo científico 2004年论文 articolo scientifico 2004年論文 mokslinis straipsnis мақолаи илмӣ 2004 nî lūn-bûn научна статия article científic wetenschappelijk artikel artikull shkencor artykuł naukowy ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ мақолаи илмӣ מאמר מדעי vedecký článok 2004년 논문 artículu científicu espublizáu en 2004 teaduslik artikkel научни чланак naučni članak vetenskaplig artikel 2004年论文 article scientific 2004年論文 vitenskapelig artikkel artículo científico publicado en 2004 scienca artikolo 2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված article scientifique (publié 2004) 2004年论文 articol științific artigo científico (publicado na 2004) 2004年の論文 научная статья επιστημονικό άρθρο videnskabelig artikel (udgivet 2004) artikulong pang-agham wissenschaftlicher Artikel บทความทางวิทยาศาสตร์ 2004年论文 2004年論文 vitskapeleg artikkel سائنسی مضمون bilimsel makale tieteellinen artikkeli bài báo khoa học 2004年论文 tudományos cikk 2004年論文 научни чланак scientific article სამეცნიერო სტატია مقالهٔ علمی مقالة علمية наукова стаття, опублікована в грудні 2004 2004年论文 artigo científico (publicado na 2004)
p:P577
wds:Q34410616-45D16E16-4740-4462-A6B1-467C91E7F9AF
wdt:P577
2004-12-01T00:00:00Z
p:P2093
wds:Q34410616-C5F5F074-A966-4AB8-A9DC-13838AA77267 wds:Q34410616-F89B3FE8-C527-4E00-8B47-D7C7070EFAB4 wds:Q34410616-179A29FD-D7DC-4B32-B5E2-E201612A383C wds:Q34410616-4124A5B0-7FB1-41B4-B9DB-87723363B4B6 wds:Q34410616-3432A1FC-CD6A-41A3-812F-7A02EE46FFDF wds:Q34410616-40D00E74-4BBB-4361-AA55-263ACFC8C463
wdt:P2093
Lisa F Kerr James K Malone Richard A Sachson John H Holcombe Lispro Mixture-Glargine Study Group Barbara N Campaigne
rdfs:label
Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy
skos:prefLabel
Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy
schema:name
Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy
p:P1476
wds:Q34410616-E5D3EC52-BEF6-4516-B55C-41BA6972B53F
wdt:P1476
Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy
p:P304
wds:Q34410616-6C8EB85A-19EC-4DD6-B177-F682B8A0A38B
wdt:P304
2034-2044
p:P31
wds:Q34410616-EAE86FD1-C7FA-4ACF-9811-B74A1A0D5D56
wdt:P31
wd:Q13442814
p:P921
wds:Q34410616-4A7E6CF2-AAD0-466A-87F0-1141BA4D3FED wds:Q34410616-88776C7D-A9D5-48A7-953A-4ECF5F30F330 wds:Q34410616-E9A9A96C-99C4-4544-A6B0-6AED27886A57 wds:Q34410616-9DC48A19-6951-4363-93E5-3C44DF4F3B01 wds:Q34410616-C31B32FF-5F58-495D-85D3-E2804EC90AD2 wds:Q34410616-DE007AEA-F72C-421C-846E-F6C48F424ABA
wdt:P921
wd:Q181600 wd:Q417317 wd:Q7240673 wd:Q19484 wd:Q2002370 wd:Q3025883
p:P698
wds:Q34410616-9A24B3C2-A2D7-44EE-9581-DA7BBA9339EC
wdtn:P698
n11:15823767
wdt:P698
15823767
p:P1433
wds:Q34410616-D31B9E52-69F0-45C6-8C19-2C1FD91881B4
wdt:P1433
wd:Q15716601
p:P433
wds:Q34410616-D8110363-3499-4825-92CB-75D4925C8C67
p:P478
wds:Q34410616-33E011B3-1916-4B14-A288-1A7237177C7E
wdt:P433
12
wdt:P478
26
p:P356
wds:Q34410616-8210222B-55B2-47FB-A7EE-B12F53AE8EC7
wdtn:P356
n12:J.CLINTHERA.2004.12.015
wdt:P356
10.1016/J.CLINTHERA.2004.12.015